| GC47773-1mg |
|
— |
N-hexanoyl-L-Homoserine lactone-d3
|
0 |
C10H14D3NO3 |
|
|
|
| GC47773-500μg |
|
— |
N-hexanoyl-L-Homoserine lactone-d3
|
0 |
C10H14D3NO3 |
|
|
|
| GC47772-25mg |
|
106983-28-2 |
N-hexanoyl-DL-Homoserine lactone
|
0 |
C10H17NO3 |
|
|
|
| GC47772-10mg |
|
106983-28-2 |
N-hexanoyl-DL-Homoserine lactone
|
0 |
C10H17NO3 |
|
|
|
| GC47772-5mg |
|
106983-28-2 |
N-hexanoyl-DL-Homoserine lactone
|
0 |
C10H17NO3 |
|
|
|
| GC47771-10mg |
|
— |
NG 25 (hydrochloride hydrate)
|
0 |
C29H30F3N5O2.3HCl [XH2O] |
|
|
|
| GC47771-5mg |
|
— |
NG 25 (hydrochloride hydrate)
|
0 |
C29H30F3N5O2.3HCl [XH2O] |
|
|
|
| GC47771-1mg |
|
— |
NG 25 (hydrochloride hydrate)
|
0 |
C29H30F3N5O2.3HCl [XH2O] |
|
|
|
| GC47770-5mg |
|
1051418-95-1 |
|
0 |
C15H10D4N4O |
|
|
|
| GC47770-1mg |
|
1051418-95-1 |
|
0 |
C15H10D4N4O |
|
|
|
| GC47769-1mg |
|
— |
Neuropeptide S (human) (acetate)
|
0 |
C93H155N31O28S.XC2H4O2 |
|
|
|
| GC47769-500μg |
|
— |
Neuropeptide S (human) (acetate)
|
0 |
C93H155N31O28S.XC2H4O2 |
|
|
|
| GC47768-5mg |
|
— |
Neuromedin U-25 (human) (trifluoroacetate salt)
|
0 |
C141H203N41O38.XCF3COOH |
|
|
|
| GC47768-1mg |
|
— |
Neuromedin U-25 (human) (trifluoroacetate salt)
|
0 |
C141H203N41O38.XCF3COOH |
|
|
|
| GC47768-500μg |
|
— |
Neuromedin U-25 (human) (trifluoroacetate salt)
|
0 |
C141H203N41O38.XCF3COOH |
|
|
|
| GC47767-50mg |
|
1157739-24-6 |
N-ethyl-N-Methylcathinone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC47767-10mg |
|
1157739-24-6 |
N-ethyl-N-Methylcathinone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC47767-5mg |
|
1157739-24-6 |
N-ethyl-N-Methylcathinone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC47766-50mg |
|
— |
N-Ethylbuphedrone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
| GC47766-10mg |
|
— |
N-Ethylbuphedrone (hydrochloride)
|
0 |
C12H17NO.HCl |
|
|
|
